Cerebral arteriovenous malformations (AVM) are vascular anomalies which consist of a conglomerate of dysplastic vessels with abnormal connections between feeding arteries and draining veins with no intervening capillary communication. Given the high arteriovenous flow, there is significant stress on the vessel wall which can lead to rupture and hemorrhage. Cerebral arteriovenous malformations are the leading cause of intracerebral hemorrhage in younger population. Other than that, AVMs can cause seizures, headaches and focal neurologic deficits because of their mass effect and vascular steal syndrome. They are usually diagnosed during etiologic intracerebral hemorrhage work up. Gold standard for the diagnosis of AVMs is digital subtraction angiography which allows visualization of the AVM, morphologically and its angioarchitectural characteristics. They are most commonly classified using Spetzler-Martin classification which considers lesion size, presence of deep vein drainage and eloquence of the brain tissue where the malformation is located. While AVM rupture is an indication for their treatment, in non-ruptured malformations the assessment of natural history risk versus risk during treatment is very important. Presence and severity of symptoms must be considered as well. Treatment of AVMs uses a multimodal approach and includes endovascular, microsurgical and radiosurgical treatment. With the development of new technologies and embolic agents, endovascular treatment is becoming more popular. It can be used as curative therapy or, more commonly, as adjuvant therapy which precedes microsurgical or radiosurgical treatment. When used as adjuvant therapy, endovascular embolization aims to make an inoperable lesion operable, decrease complication risk during microsurgical procedures and decrease lesion size and therefore make it suitable for stereotactic radiosurgical treatment. Furthermore, endovascular embolization is used in ruptured AVMs as repeated aneurism hemorrhage prevention as well as symptomatic therapy in patients who are not suitable for more invasive treatment modalities. Effectiveness of endovascular treatment has significantly increased with the development of liquid embolic agents and microcatheters. Treatment process begins with transarterial approach and is followed with microcatheter guidance and positioning distally of the lesion feeding artery. Once the catheter is in place, superselective angiography and lesion embolization follow. New techniques are created to achieve superior and more selective embolization procedures. Endovascular treatment does include possible complications, with the most common ones being periprocedural hemorrhage and ischemic lesions which are dependent on technical and physiologic factors.